Public Employees Retirement Association of Colorado’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,417
Closed -$348K 1935
2023
Q2
$348K Hold
3,417
﹤0.01% 1263
2023
Q1
$311K Hold
3,417
﹤0.01% 1345
2022
Q4
$130K Hold
3,417
﹤0.01% 1733
2022
Q3
$86K Hold
3,417
﹤0.01% 1834
2022
Q2
$104K Hold
3,417
﹤0.01% 1819
2022
Q1
$112K Hold
3,417
﹤0.01% 1828
2021
Q4
$90K Hold
3,417
﹤0.01% 1887
2021
Q3
$344K Hold
3,417
﹤0.01% 1479
2021
Q2
$484K Hold
3,417
﹤0.01% 1251
2021
Q1
$341K Hold
3,417
﹤0.01% 1473
2020
Q4
$422K Hold
3,417
﹤0.01% 1226
2020
Q3
$333K Hold
3,417
﹤0.01% 1216
2020
Q2
$533K Hold
3,417
﹤0.01% 926
2020
Q1
$493K Hold
3,417
﹤0.01% 860
2019
Q4
$699K Sell
3,417
-558
-14% -$102K ﹤0.01% 857
2019
Q3
$319K Hold
3,975
﹤0.01% 1291
2019
Q2
$375K Buy
+3,975
New +$343K ﹤0.01% 1235

Other funds holding RETA

Public Employees Retirement Association of Colorado's RETA Position: Q3 2023 in Review

Public Employees Retirement Association of Colorado sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 3,417 shares — an estimated $348K sold.

Public Employees Retirement Association of Colorado first reported a position in RETA in Q2 2019 and held it in 17 quarters. The position peaked at $699K in Q4 2019. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

  • Public Employees Retirement Association of Colorado reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Public Employees Retirement Association of Colorado sold 3,417 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $348K.
  • Public Employees Retirement Association of Colorado first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2019 and held it in 17 quarters.
  • Public Employees Retirement Association of Colorado's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $699K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q3 2023, filed 14 Nov 2023.